Nitric Oxide Synthase Inhibition Decreases Output of Hepatic Insulin Sensitizing Substance (Hiss), Which Is Reversed by Sin-1 but Not by Nitroprusside

AuthID
 P-000-XSW
4
Author(s)
Correia, NC
·
1
Editor(s)
Huxtable, RJ
Document Type
Proceedings Paper
Year published
2001
Published
in PROCEEDINGS OF THE WESTERN PHARMACOLOGY SOCIETY in PROCEEDINGS OF THE WESTERN PHARMACOLOGY SOCIETY, ISSN: 0083-8969
Volume: 44, Pages: 25-26 (2)
Conference
44Th Annual Meeting of the Western-Pharmacology-Society, Date: MAR 25-29, 2001, Location: VANCOUVER, CANADA, Sponsors: Western Pharmocol Soc, GlaxoSmithKline, Pfizer Global Res & Dev USA/Pfizer Canada, Merck Frostt Canada, Merch Res Lab, Roch Biosci, Nortran Pharmaceut, Cardiome Pharma Corp, Astra Zeneca, Novartis Canada
Indexing
Wos®
Scopus®
Pubmed®
Publication Identifiers
Pubmed: 11793984
SCOPUS: 2-s2.0-0035699836
Wos: WOS:000174317500007
Source Identifiers
ISSN: 0083-8969
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

A place for researchers and their institutions

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service